EUVIMEDEUVIMED entdecken
Leitlinie

Publication Requirements and Guidelines for Protein Kinase Inhibitor Studies in the Journal of Medicinal Chemistry: A 2026 Update

David E. Heppner, Fleur M. Ferguson, Alison D. Axtman, Stefan A. Laufer

Journal of Medicinal Chemistry · 12.11.2026

DOI: 10.1021/acs.jmedchem.6c03341 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 12.11.2026. Verfasst von David E. Heppner und 3 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Heppner, D. E., Ferguson, F. M., Axtman, A. D., & Laufer, S. A. (2026). Publication Requirements and Guidelines for Protein Kinase Inhibitor Studies in the Journal of Medicinal Chemistry: A 2026 Update. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c03341

Vancouver

Heppner DE, Ferguson FM, Axtman AD, Laufer SA. Publication Requirements and Guidelines for Protein Kinase Inhibitor Studies in the Journal of Medicinal Chemistry: A 2026 Update. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c03341

BibTeX
@article{Heppner2026,
  author = {Heppner, David E. and Ferguson, Fleur M. and Axtman, Alison D. and Laufer, Stefan A.},
  title = {Publication Requirements and Guidelines for Protein Kinase Inhibitor Studies in the Journal of Medicinal Chemistry: A 2026 Update},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c03341}
}
Kostenlos starten →